Peyrin-Biroulet L, Arkkila P, Armuzzi A, Atreya R, Danese S, Ferrante M, Guardiola J, Jahnsen J, Louis E, Lukas M, Reinisch W, Roblin X, Smith PJ, Kwon TS, Kim JY, Yoon SW, Kim DH (2022)
Publication Type: Conference contribution
Publication year: 2022
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: I1116-I117
Conference Proceedings Title: JOURNAL OF CROHNS & COLITIS
DOI: 10.1093/ecco-jcc/jjab232.112
APA:
Peyrin-Biroulet, L., Arkkila, P., Armuzzi, A., Atreya, R., Danese, S., Ferrante, M.,... Kim, D.H. (2022). A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis. In JOURNAL OF CROHNS & COLITIS (pp. I1116-I117). OXFORD: OXFORD UNIV PRESS.
MLA:
Peyrin-Biroulet, L., et al. "A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis." Proceedings of the JOURNAL OF CROHNS & COLITIS OXFORD: OXFORD UNIV PRESS, 2022. I1116-I117.
BibTeX: Download